pharmacoeconomic evaluation of antidiabetic drugs
Not Applicable
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complicationsHealth Condition 2: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2023/07/055043
- Lead Sponsor
- Deeksha M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients of age 18 years and above of both genders. patients who have be admitted to general medicine and OPD with type 2 diabetes mellitus.
Exclusion Criteria
patients with pregnant and lactating women, patients on insulin therapy, patients with type 1 diabetes, patients with cognitive impairment and patients in ICU.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study results will give an overview of cost effectiveness of oral antidiabetic drugs on type 2 diabetics patients which helps in selecting effective drug & also improves patients outcome by selecting proper drug therapy & also determines the minimum & maximum percentage price variation for different classes of oral antidiabetic drugsTimepoint: 015 30DAYS
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil